168 related articles for article (PubMed ID: 28449585)
21. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
[TBL] [Abstract][Full Text] [Related]
22. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M
J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084
[TBL] [Abstract][Full Text] [Related]
23. Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.
Schupf N; Zigman WB; Tang MX; Pang D; Mayeux R; Mehta P; Silverman W
Neurology; 2010 Nov; 75(18):1639-44. PubMed ID: 21041786
[TBL] [Abstract][Full Text] [Related]
24. Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.
Blennow K; De Meyer G; Hansson O; Minthon L; Wallin A; Zetterberg H; Lewczuk P; Vanderstichele H; Vanmechelen E; Kornhuber J; Wiltfang J; ; Heuser I; Maier W; Luckhaus C; Rüther E; Hüll M; Jahn H; Gertz HJ; Frölich L; Hampel H; Pernetzki R
J Nutr Health Aging; 2009 Mar; 13(3):205-8. PubMed ID: 19262954
[TBL] [Abstract][Full Text] [Related]
25. Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
Chong JR; Ashton NJ; Karikari TK; Tanaka T; Saridin FN; Reilhac A; Robins EG; Nai YH; Vrooman H; Hilal S; Zetterberg H; Blennow K; Lai MKP; Chen CP
Alzheimers Dement; 2021 Oct; 17(10):1649-1662. PubMed ID: 33792168
[TBL] [Abstract][Full Text] [Related]
26. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
[TBL] [Abstract][Full Text] [Related]
27. Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
Cai Y; Shi D; Lan G; Chen L; Jiang Y; Zhou L; Guo T;
Neurology; 2024 Apr; 102(7):e209205. PubMed ID: 38489560
[TBL] [Abstract][Full Text] [Related]
28. Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease.
Tzen KY; Yang SY; Chen TF; Cheng TW; Horng HE; Wen HP; Huang YY; Shiue CY; Chiu MJ
ACS Chem Neurosci; 2014 Sep; 5(9):830-6. PubMed ID: 25054847
[TBL] [Abstract][Full Text] [Related]
29. Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment.
Cammarata S; Borghi R; Giliberto L; Pardini M; Pollero V; Novello C; Fornaro M; Vitali A; Bracco L; Caltagirone C; Bossù P; Odetti P; Tabaton M
J Alzheimers Dis; 2009; 18(2):267-71. PubMed ID: 19584444
[TBL] [Abstract][Full Text] [Related]
30. Association of Midlife Plasma Amyloid-β Levels With Cognitive Impairment in Late Life: The ARIC Neurocognitive Study.
Sullivan KJ; Blackshear C; Simino J; Tin A; Walker KA; Sharrett AR; Younkin S; Gottesman RF; Mielke MM; Knopman D; Windham BG; Griswold ME; Mosley TH
Neurology; 2021 Sep; 97(11):e1123-e1131. PubMed ID: 34349010
[TBL] [Abstract][Full Text] [Related]
31. Plasma β-amyloid in Alzheimer's disease and vascular disease.
Janelidze S; Stomrud E; Palmqvist S; Zetterberg H; van Westen D; Jeromin A; Song L; Hanlon D; Tan Hehir CA; Baker D; Blennow K; Hansson O
Sci Rep; 2016 May; 6():26801. PubMed ID: 27241045
[TBL] [Abstract][Full Text] [Related]
32. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.
Schindler SE; Bollinger JG; Ovod V; Mawuenyega KG; Li Y; Gordon BA; Holtzman DM; Morris JC; Benzinger TLS; Xiong C; Fagan AM; Bateman RJ
Neurology; 2019 Oct; 93(17):e1647-e1659. PubMed ID: 31371569
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor.
Gao H; Liu M; Zhao Z; Yang C; Zhu L; Cai Y; Yang Y; Hu Z
ACS Appl Mater Interfaces; 2020 Feb; 12(8):9693-9700. PubMed ID: 32013375
[TBL] [Abstract][Full Text] [Related]
34. Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.
Goos JD; Teunissen CE; Veerhuis R; Verwey NA; Barkhof F; Blankenstein MA; Scheltens P; van der Flier WM
Neurobiol Aging; 2012 May; 33(5):1011.e1-9. PubMed ID: 22118945
[TBL] [Abstract][Full Text] [Related]
35. The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.
Giedraitis V; Sundelöf J; Irizarry MC; Gårevik N; Hyman BT; Wahlund LO; Ingelsson M; Lannfelt L
Neurosci Lett; 2007 Nov; 427(3):127-31. PubMed ID: 17936506
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
37. Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis.
Iulita MF; Ganesh A; Pentz R; Flores Aguilar L; Gubert P; Ducatenzeiler A; Christie S; Wilcock GK; Cuello AC
J Alzheimers Dis; 2019; 67(1):327-341. PubMed ID: 30636741
[TBL] [Abstract][Full Text] [Related]
38. Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.
Verberk IMW; Slot RE; Verfaillie SCJ; Heijst H; Prins ND; van Berckel BNM; Scheltens P; Teunissen CE; van der Flier WM
Ann Neurol; 2018 Nov; 84(5):648-658. PubMed ID: 30196548
[TBL] [Abstract][Full Text] [Related]
39. Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.
Takeda S; Sato N; Uchio-Yamada K; Yu H; Moriguchi A; Rakugi H; Morishita R
Dement Geriatr Cogn Disord; 2012; 34(1):25-30. PubMed ID: 22889768
[TBL] [Abstract][Full Text] [Related]
40. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
Hanon O; Vidal JS; Lehmann S; Bombois S; Allinquant B; Tréluyer JM; Gelé P; Delmaire C; Blanc F; Mangin JF; Buée L; Touchon J; Hugon J; Vellas B; Galbrun E; Benetos A; Berrut G; Paillaud E; Wallon D; Castelnovo G; Volpe-Gillot L; Paccalin M; Robert PH; Godefroy O; Dantoine T; Camus V; Belmin J; Vandel P; Novella JL; Duron E; Rigaud AS; Schraen-Maschke S; Gabelle A;
Alzheimers Dement; 2018 Jul; 14(7):858-868. PubMed ID: 29458036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
